NCT03666754

Brief Summary

The study evaluates the effects of early endovenous glue ablation on ulcer healing in patients with chronic venous ulceration. Half the patients are randomized to receive early endovenous ablation (within 2 weeks) and a half to standard care

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 12, 2018

Completed
14 days until next milestone

Study Start

First participant enrolled

September 26, 2018

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

December 17, 2021

Status Verified

December 1, 2021

Enrollment Period

5.3 years

First QC Date

September 10, 2018

Last Update Submit

December 16, 2021

Conditions

Keywords

Venous Leg UlcerGlue embolizationsaphenous vein reflux

Outcome Measures

Primary Outcomes (1)

  • Time to ulcer healing

    For the purposes of this study, ulcer healing is defined as complete re-epithelialization of all ulceration on the randomized (reference) leg in the absence of a scab (eschar) with no dressing required.

    time from date of randomisation to date of healing within the 12 month study period

Secondary Outcomes (8)

  • Ulcer Healing Rate

    24 weeks & time to ulcer healing within the 12 month study period

  • Ulcer recurrence / Ulcer Free Time

    Up to 12 months

  • Quality Of Life SF36

    6 weeks post randomisation, 6 months, 12 months

  • Quality Of Life CIVIQ-20

    6 weeks post randomisation, 6 months, 12 months

  • Quality Of Life EQ5D

    6 weeks post randomisation, 6 months, 12 months

  • +3 more secondary outcomes

Study Arms (2)

Standard therapy arm

ACTIVE COMPARATOR

Multilayer elastic compression bandaging/ stockings with the deferred treatment of superficial reflux (usually once the ulcer has healed)

Procedure: Standard therapy arm

Early endovenous glue embolization arm

EXPERIMENTAL

Early endovenous glue embolization of superficial venous reflux within 2 weeks in addition to standard compression therapy

Procedure: Early endovenous glue embolization arm

Interventions

Multilayer elastic compression bandaging/ stockings with the deferred treatment of superficial reflux (usually once the ulcer has healed)

Standard therapy arm

Early endovenous glue embolization of superficial venous reflux within 2 weeks in addition to standard compression therapy

Early endovenous glue embolization arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current leg ulceration of greater than 6 weeks, but less than 6 months duration
  • Able to give informed consent to participate in the study after reading the patient information documentation
  • Patient age \> 18 years
  • Ankle Brachial Pressure Index (ABPI) ≥ 0.8
  • Superficial venous disease on colour duplex assessment deemed to be significant enough to warrant ablation by the treating clinician (either primary or recurrent venous reflux)

You may not qualify if:

  • Presence of deep venous occlusive disease or other conditions precluding superficial venous intervention
  • Patients who are unable to tolerate any multilayer compression bandaging / stockings will be excluded.
  • The inability of the patient to receive the prompt endovenous intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vascular Surgery, Siriraj Hospital, Mahidol University

Bangkoknoi, Bangkok, 10700, Thailand

RECRUITING

MeSH Terms

Conditions

Varicose Ulcer

Condition Hierarchy (Ancestors)

Varicose VeinsVascular DiseasesCardiovascular DiseasesLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Nuttawut Sermsathanasawadi, MD

    Mahidol University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nuttawut Sermsathanasawadi,, MD

CONTACT

Nuttawut Sermsathanasawadi, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The randomised clinical trial with participants randomised1:1 to either: 'Standard' therapy consisting of multilayer elastic compression bandaging/ stockings with deferred treatment of superficial reflux (usually once the ulcer has healed) Early endovenous glue embolization of superficial venous reflux(within 2 weeks) in addition to standard therapy
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2018

First Posted

September 12, 2018

Study Start

September 26, 2018

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

December 17, 2021

Record last verified: 2021-12

Locations